BioSpace News Archive

Career Advice

5 Reasons Why Most People Are Not Happy at Work

Many people face difficulties at work which becomes a reason for them to be unhappy. Here are some of the reasons why most workers are not happy at work.

September 14, 2018
·
4 min read
·
Porschia Parker
Pharm Country

Botanix presents at European Dermatology Conference

Botanix will be presenting at the 27th EADV Congress in Paris, France

September 14, 2018
·
1 min read
Deals

Galapagos raises $300 million gross proceeds in a U.S. public offering

Galapagos NV announced today the pricing of its U.S. public offering totaling $300 million gross proceeds of 2,575,107 new ordinary shares in the form of American Depositary Shares (“ADSs”) at $116.50 per ADS, before underwriting discounts.

September 14, 2018
·
6 min read
Policy

Atlantic Healthcare secures acceptance of brand name Camligo™ for alicaforsen enema to treat pouchitis

Atlantic Healthcare plc has secured acceptance of Camligo™ as the name for the Company’s first candidate product.

September 14, 2018
·
5 min read
Recipharm connects to European Hub for serialisation compliance

Recipharm, a leading contract development and manufacturing organisation (CDMO) has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European Hub.

September 14, 2018
·
4 min read
Business

Rostec to build unique oncology treatment center in Russian Far East

Rostec and the administration of the Primorsky Krai, a federal subject in the Russian Far East, have signed an agreement to establish an oncology center of proton therapy in the Primorsky region. The health clinic shall admit its first patients in 2022, its annual capacity shall be over 1000 patients.

September 14, 2018
·
3 min read
Deals

EMBL Ventures Portfolio Company, ViraTherapeutics Acquired by Boehringer Ingelheim in EUR 210 million (USD 245 million) Transaction

ViraTherapeutics sale marks third exit from EMBL Ventures’ current fund ETF II Heidelberg, Germany, 13th Sept

September 14, 2018
·
5 min read
Business

Global Joint Venture in Shanghai to Bring Advanced Cell Therapies to Multi-Billion Dollar Patient Population in China

Advanced Cell Therapy Shanghai Summit October 29-31, 2018

September 14, 2018
·
4 min read
Lone Star Bio

Texas A&M selected by HRSA to lead center addressing American rural health care

Texas A&M has been chosen as the recipient of a five-year grant from the Vulnerable Rural Hospitals Assistance Program, funded by the Health Resources and Services Administration (HRSA), an agency of the U.S. Department of Health and Human Services.

September 14, 2018
·
4 min read
Drug Development

Galapagos and MorphoSys announce start of a Phase 1 subcutaneous bridging study with MOR106

Galapagos NV and MorphoSys AG announced today the initiation of a Phase 1 bridging study testing a subcutaneous formulation of MOR106, an investigational antibody directed against IL-17C.

September 14, 2018
·
7 min read